Wooldridge J, Bergeron J, Thornton C
Mathematica Policy Research Inc, Princeton, NJ, USA.
Am J Public Health. 1996 Jul;86(7):935-8. doi: 10.2105/ajph.86.7.935.
Every year about 38,000 elderly people with diabetes have a lower extremity amputation. Therapeutic shoes are prescribed by clinicians specializing in foot care to prevent foot ulcerations and amputations among at-risk patients with diabetes. Medicare ran a 3-year demonstration of a therapeutic-shoe benefit for beneficiaries with diabetes. Medicare added the benefit nationwide in May 1993.
This paper describes the benefit and its implementation in the demonstration based on demonstration records, a patient survey, and discussions with clinicians and shoe suppliers before and during the demonstration.
During the demonstration, far fewer beneficiaries applied for the therapeutic shoes than were eligible for them. The paper discusses reasons for the low beneficiary application rate and the associated low participation rate among physicians treating patients with diabetes.
The benefit is unlikely to be used any more in the national program than in the demonstration unless physicians are educated in the role therapeutic shoes can play in diabetic foot disease, they prescribe the shoes for their patients, and they increase their patients' awareness of the shoes' value.
每年约有38000名老年糖尿病患者接受下肢截肢手术。足部护理专科临床医生会为有糖尿病足风险的患者开具治疗性鞋子的处方,以预防足部溃疡和截肢。医疗保险针对糖尿病受益患者进行了为期3年的治疗性鞋子福利示范项目。1993年5月,医疗保险在全国范围内增加了这项福利。
本文基于示范项目记录、患者调查以及在示范项目之前和期间与临床医生和鞋子供应商的讨论,描述了该福利及其在示范项目中的实施情况。
在示范项目期间,申请治疗性鞋子的受益人数远低于符合条件的人数。本文讨论了受益患者申请率低以及治疗糖尿病患者的医生参与率低的原因。
除非医生了解治疗性鞋子在糖尿病足疾病中所能发挥的作用,为患者开具这种鞋子的处方,并提高患者对鞋子价值的认识,否则在全国项目中,这项福利的使用情况可能不会比在示范项目中更好。